Bayer Cropscience Ltd
NSE:BAYERCROP

Watchlist Manager
Bayer Cropscience Ltd Logo
Bayer Cropscience Ltd
NSE:BAYERCROP
Watchlist
Price: 5 737.05 INR -0.87% Market Closed
Market Cap: 257.8B INR
Have any thoughts about
Bayer Cropscience Ltd?
Write Note

Intrinsic Value

The intrinsic value of one BAYERCROP stock under the Base Case scenario is 4 347.51 INR. Compared to the current market price of 5 737.05 INR, Bayer Cropscience Ltd is Overvalued by 24%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

BAYERCROP Intrinsic Value
4 347.51 INR
Overvaluation 24%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Bayer Cropscience Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for BAYERCROP cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about BAYERCROP?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Bayer Cropscience Ltd

Provide an overview of the primary business activities
of Bayer Cropscience Ltd.

What unique competitive advantages
does Bayer Cropscience Ltd hold over its rivals?

What risks and challenges
does Bayer Cropscience Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Bayer Cropscience Ltd.

Provide P/S
for Bayer Cropscience Ltd.

Provide P/E
for Bayer Cropscience Ltd.

Provide P/OCF
for Bayer Cropscience Ltd.

Provide P/FCFE
for Bayer Cropscience Ltd.

Provide P/B
for Bayer Cropscience Ltd.

Provide EV/S
for Bayer Cropscience Ltd.

Provide EV/GP
for Bayer Cropscience Ltd.

Provide EV/EBITDA
for Bayer Cropscience Ltd.

Provide EV/EBIT
for Bayer Cropscience Ltd.

Provide EV/OCF
for Bayer Cropscience Ltd.

Provide EV/FCFF
for Bayer Cropscience Ltd.

Provide EV/IC
for Bayer Cropscience Ltd.

Show me price targets
for Bayer Cropscience Ltd made by professional analysts.

What are the Revenue projections
for Bayer Cropscience Ltd?

How accurate were the past Revenue estimates
for Bayer Cropscience Ltd?

What are the Net Income projections
for Bayer Cropscience Ltd?

How accurate were the past Net Income estimates
for Bayer Cropscience Ltd?

What are the EPS projections
for Bayer Cropscience Ltd?

How accurate were the past EPS estimates
for Bayer Cropscience Ltd?

What are the EBIT projections
for Bayer Cropscience Ltd?

How accurate were the past EBIT estimates
for Bayer Cropscience Ltd?

Compare the revenue forecasts
for Bayer Cropscience Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Bayer Cropscience Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Bayer Cropscience Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Bayer Cropscience Ltd compared to its peers.

Compare the P/E ratios
of Bayer Cropscience Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Bayer Cropscience Ltd with its peers.

Analyze the financial leverage
of Bayer Cropscience Ltd compared to its main competitors.

Show all profitability ratios
for Bayer Cropscience Ltd.

Provide ROE
for Bayer Cropscience Ltd.

Provide ROA
for Bayer Cropscience Ltd.

Provide ROIC
for Bayer Cropscience Ltd.

Provide ROCE
for Bayer Cropscience Ltd.

Provide Gross Margin
for Bayer Cropscience Ltd.

Provide Operating Margin
for Bayer Cropscience Ltd.

Provide Net Margin
for Bayer Cropscience Ltd.

Provide FCF Margin
for Bayer Cropscience Ltd.

Show all solvency ratios
for Bayer Cropscience Ltd.

Provide D/E Ratio
for Bayer Cropscience Ltd.

Provide D/A Ratio
for Bayer Cropscience Ltd.

Provide Interest Coverage Ratio
for Bayer Cropscience Ltd.

Provide Altman Z-Score Ratio
for Bayer Cropscience Ltd.

Provide Quick Ratio
for Bayer Cropscience Ltd.

Provide Current Ratio
for Bayer Cropscience Ltd.

Provide Cash Ratio
for Bayer Cropscience Ltd.

What is the historical Revenue growth
over the last 5 years for Bayer Cropscience Ltd?

What is the historical Net Income growth
over the last 5 years for Bayer Cropscience Ltd?

What is the current Free Cash Flow
of Bayer Cropscience Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Bayer Cropscience Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Bayer Cropscience Ltd

Current Assets 39.1B
Cash & Short-Term Investments 10.8B
Receivables 10.6B
Other Current Assets 17.7B
Non-Current Assets 6.9B
Long-Term Investments 251m
PP&E 3.8B
Intangibles 1.3B
Other Non-Current Assets 1.6B
Current Liabilities 16B
Accounts Payable 6.1B
Accrued Liabilities 8m
Other Current Liabilities 9.9B
Non-Current Liabilities 1.5B
Long-Term Debt 210m
Other Non-Current Liabilities 1.3B
Efficiency

Earnings Waterfall
Bayer Cropscience Ltd

Revenue
49.9B INR
Cost of Revenue
-29B INR
Gross Profit
21B INR
Operating Expenses
-13.2B INR
Operating Income
7.8B INR
Other Expenses
-1.1B INR
Net Income
6.7B INR

Free Cash Flow Analysis
Bayer Cropscience Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

BAYERCROP Profitability Score
Profitability Due Diligence

Bayer Cropscience Ltd's profitability score is 63/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Year Average ROE
Positive 3-Year Average ROIC
Positive Free Cash Flow
63/100
Profitability
Score

Bayer Cropscience Ltd's profitability score is 63/100. The higher the profitability score, the more profitable the company is.

BAYERCROP Solvency Score
Solvency Due Diligence

Bayer Cropscience Ltd's solvency score is 93/100. The higher the solvency score, the more solvent the company is.

93/100
Solvency
Score

Bayer Cropscience Ltd's solvency score is 93/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BAYERCROP Price Targets Summary
Bayer Cropscience Ltd

Wall Street analysts forecast BAYERCROP stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BAYERCROP is 6 174.35 INR with a low forecast of 5 489.35 INR and a high forecast of 7 381.5 INR.

Lowest
Price Target
5 489.35 INR
4% Downside
Average
Price Target
6 174.35 INR
8% Upside
Highest
Price Target
7 381.5 INR
29% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for BAYERCROP?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for BAYERCROP is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Bayer Cropscience Ltd Logo
Bayer Cropscience Ltd

Country

India

Industry

Chemicals

Market Cap

257.8B INR

Dividend Yield

0.61%

Description

Bayer CropScience Ltd. engages in the manufacture, sale, and distribution of crop protection products. The company is headquartered in Thane, Maharashtra and currently employs 1,318 full-time employees. The company went IPO on 2010-01-08. The firm operates through Agri Care segment. The company offers crop solutions for various crops, such as cotton, fruits, millet, mustard, pulses, rice, soybeans, sugar cane, vegetables and wheat. The firm offers various pest management solutions, such as Professional Pest Management for household / structural pests and Vector Management for pests that pose a threat to public health. The company offers various brands, such as Aliette, Antracol, Folicur, Melody Duo and Nativo under the fungicides category; Adora, Atlantis, Laudis, Lucifer, Raft, Ricestar and Topstar under the herbicides category; Admire, Alanto, Confidor, Decis 100, Fame, Flotis, Jump, Larvin and Spintor under the insecticides category; Emesto Prime, Gaucho and Raxil Easy under the SeedGrowth category, and Ethrel and Planofix under the others category.

Contact

MAHARASHTRA
Thane
Bayer House, Central Avenue, Hiranandani Estate, Thane (West)
+912225711234
bayer.in

IPO

2010-01-08

Employees

1 318

Officers

Vice Chairman, MD & CEO
Mr. Simon Thorsten Wiebusch
CFO & Whole Time Director
Mr. Simon Johannes Britsch
Company Secretary & Compliance Officer
Ms. Bharati Shetty
VP of Marketing & Co-operations
Mr. Anil Jain
Country Division Head of the Pharmaceutical Division
Ms. Shweta Rai
Country Group Mngr of Environmental Science for India, Sri Lanka & for Nepal
Mr. Dinesh S. Bapat

See Also

Discover More
What is the Intrinsic Value of one BAYERCROP stock?

The intrinsic value of one BAYERCROP stock under the Base Case scenario is 4 347.51 INR.

Is BAYERCROP stock undervalued or overvalued?

Compared to the current market price of 5 737.05 INR, Bayer Cropscience Ltd is Overvalued by 24%.

Back to Top